Cas:1190978-94-9 4,7-dibroMo-5,6-bis(hexyloxy)benzo[c][1,2,5]thiadiazole manufacturer & supplier

Chemical Name:4,7-dibroMo-5,6-bis(hexyloxy)benzo[c][1,2,5]thiadiazole

CAS.NO:1190978-94-9

Synonyms:4,7-dibromo-5,6-bis-hexyloxy-benzo[1,2,5]thiadiazole;4,7-dibromo-5,6-bis(hexyloxy)benzo[c][1,2,5]thiadiazole

Molecular Formula:C₁₈H₂₆Br₂N₂O₂S

Molecular Weight:494.28400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:72.48000

Exact Mass:492.00800

LogP:7.13450

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4,7-dibromo-5,6-bis-hexyloxy-benzo[1,2,5]thiadiazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,7-dibromo-5,6-bis(hexyloxy)benzo[c][1,2,5]thiadiazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,7-dibromo-5,6-bis-hexyloxy-benzo[1,2,5]thiadiazole Use and application,4,7-dibromo-5,6-bis(hexyloxy)benzo[c][1,2,5]thiadiazole technical grade,usp/ep/jp grade.

Related News: We are committed to bringing safe, effective vaccines to Ireland and other markets as quickly as possible, and Charles River will continue to be an important partner in this regard.” Distillates,hydrocarbon resin prodn. higher boiling manufacturers Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial. 2-({4-[(2S)-3-amino-2-ethoxypropyl]phenoxy}methyl)-3-methylquinazolin-4(3H)-one suppliers In Massachusetts, where the bulk of Takeda’s U.S. operations are based since the Shire buyout, the Japanese pharma has been swiftly ramping up its cell therapy ambitions. In September, the company cut the ribbon on a new 24,000-square-foot R&D manufacturing center in Boston, which it said at the time would handle clinical development for three ongoing pipeline programs and two other prospects pegged to enter clinical development by the end of 2021. radium-228 vendor & factory.